Scientific basis of strategies for schistosomiasis control and prospect of the 14th Five-Year Plan in China

doi:10.12140/j.issn.1000-7423.2022.04.002

Abstract

Abstract:

Schistosomiasis has been endemic in China for more than 2 000 years, seriously endangering the population’s health and affecting economic development. According to the epidemic characteristics of schistosomiasis, different strategies have been implemented in different historical periods in China to control schistosomiasis. Under the guidance of different strategies, China has achieved remarkable results in schistosomiasis control. The target of schistosomiasis transmission control was achieved nationwide in 2015. The strategies of schistosomiasis control in different periods of China all follow certain scientific basis and rules. This paper reviews the scientific basis of different strategies for schistosomiasis control and puts forward some thoughts and suggestions for schistosomiasis intervention strategies during the 14th Five-Year Plan period to be helpful for the elimination of schistosomiasis.

Key words: Schistosomiasis, Control strategy, Scientific basis

CLC Number:

R532.2

FENG Jia-xin, GONG Yan-feng, LUO Zhuo-wei, WANG Wei, CAO Chun-li, XU Jing, LI Shi-zhu. Scientific basis of strategies for schistosomiasis control and prospect of the 14th Five-Year Plan in China[J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2022, 40(4): 428-435.

References 73

[1]	Ebisawa I. Epidemiology and eradication of schistosomiasis japonica in Japan[J]. J Travel Med, 1998, 5(1): 33-35. pmid: 9772314
[2]	Mao SP, Shao BR. Schistosomiasis control in the people’s Republic of China[J]. Am J Trop Med Hyg, 1982, 31(1): 92-99. pmid: 7058983
[3]	Zhou XN, Wang LY, Chen MG, et al. The public health significance and control of schistosomiasis in China: then and now[J]. Acta Trop, 2005, 96(2/3): 97-105. doi: 10.1016/j.actatropica.2005.07.005
[4]	Hao Y, Zheng H, Zhu R, et al. Endemic status of schistosomiasis in People’s Republic of China in 2008[J]. Chin J Schisto Control, 2009, 21(6): 451-456. (in Chinese)
	( 郝阳, 郑浩, 朱蓉, 等. 2008年全国血吸虫病疫情通报[J]. 中国血吸虫病防治杂志, 2009, 21(6): 451-456.)
[5]	Song LG, Wu XY, Sacko M, et al. History of schistosomiasis epidemiology, current status, and challenges in China: on the road to schistosomiasis elimination[J]. Parasitol Res, 2016, 115(11): 4071-4081. doi: 10.1007/s00436-016-5253-5
[6]	Wang QZ, Wang TP, Zhang SQ. Research progress on transmission capacity of reservoir host of Schistosoma japonicum[J]. Chin J Schisto Control, 2013, 25(1): 86-89. (in Chinese)
	( 汪奇志, 汪天平, 张世清. 日本血吸虫保虫宿主传播能量研究进展[J]. 中国血吸虫病防治杂志, 2013, 25(1): 86-89.)
[7]	Li FJ. Schistosomiasis in Japan and its control in China[J]. Chin Med J, 1948, 34(9): 413-424. (in Chinese)
	( 李赋京. 中国之日本住血吸虫病及其管制[J]. 中华医学杂志, 1948, 34(9): 413-424.)
[8]	Zhou XN. Send away the god of plague: documentary on the fight against schistosomiasis in New China after 1949[M]. Nanchang: Jiangxi Scientific Technical Press, 2021: 26-108. (in Chinese)
	( 周晓农. 送瘟神: 新中国抗击血吸虫病纪实[M]. 南昌: 江西科学技术出版社, 2021: 26-108.)
[9]	Editorial Board of History of schistosomiasis control in Zhejiang Province. History of schistosomiasis control in Zhejiang Province[M]. Shanghai: Shanghai Scientific Technical Publishers, 1992: 17. (in Chinese)
	( 《浙江省血吸虫病防治史》编委会. 浙江省血吸虫病防治史[M]. 上海: 上海科学技术出版社, 1992: 17.)
[10]	Wang LD. History and prospect of schistosomiasis control in China: selected essays commemorating the centenary of schistosomiasis discovery in China[M]. Beijing: People’s Medical Publishing House, 2006: 51. (in Chinese)
	( 王陇德. 中国血吸虫病防治历程与展望: 纪念血吸虫病在中国发现一百周年文选[M]. 北京: 人民卫生出版社, 2006: 51.)
[11]	Wen YG. Experience and enlightenment of schistosomiasis prevention and control in the early years of People’s Republic of China[J]. J Chang Univ, 2020, 37(6): 9-14. (in Chinese)
	( 文永刚. 中华人民共和国成立初期血吸虫病防治的经验及当代启示[J]. 长治学院学报, 2020, 37(6): 9-14.)
[12]	Chen XY, Wang LY, Cai JM, et al. Schistosomiasis control in China: the impact of a 10-year World Bank Loan Project (1992—2001)[J]. Bull World Heal Organ, 2005, 83(1): 43-48.
[13]	Xu J, Steinman P, Maybe D, et al. Evolution of the national schistosomiasis control programmes in the People’s Republic of China[J]. Adv Parasitol, 2016, 92: 1-38.
[14]	Zhang LJ, Xu ZM, Qian YJ, et al. Endemic status of schistosomiasis in People’s Republic of China in 2015[J]. Chin J Schisto Control, 2016, 28(6): 611-617. (in Chinese)
	( 张利娟, 徐志敏, 钱颖骏, 等. 2015年全国血吸虫病疫情通报[J]. 中国血吸虫病防治杂志, 2016, 28(6): 611-617.)
[15]	Zhang LJ, Xu ZM, Yang F, et al. Endemic status of schistosomiasis in People’s Republic of China in 2020[J]. Chin J Schisto Control, 2021, 33(3): 225-233. (in Chinese)
	( 张利娟, 徐志敏, 杨帆, 等. 2020年全国血吸虫病疫情通报[J]. 中国血吸虫病防治杂志, 2021, 33(3): 225-233.)
[16]	Mao SB. Some unsolved problems in schistosomiasis research in China[J]. Chin J Prev Med, 1954(2): 111-116. (in Chinese)
	( 毛守白. 国内血吸虫病研究方面尚待解决的若干问题[J]. 中华预防医学杂志, 1954(2): 111-116.)
[17]	Chopra RN. An experimental investigation into the action of organic compounds of antimony[J]. Indian J Med Res, 1927: 41-48.
[18]	Lippincott SW, Paddock FK. Tests of liver function in schistosomiasis japonica with particular reference to antimony treatment and with report of two autopsies[J]. Arch Intern Med, 1947, 79(1): 62-76. doi: 10.1001/archinte.1947.00220070058001
[19]	Christopherson JB, Roodhouse GS. The biochemical action of intravenous antimony tartrate injections[J]. Lancet, 1926, 207(5344): 227-229. doi: 10.1016/S0140-6736(01)15587-X
[20]	McKenzie A. Fatalities following the administration of intravenous tartar emetic[J]. Trans R Soc Trop Med Hyg, 1932, 25(5): 407-410. doi: 10.1016/S0035-9203(32)90160-6
[21]	Mao SB. Achievements in schistosomiasis control research in New China[J]. Chin Sci Bull, 1960, 5(12): 368-371. (in Chinese)
	( 毛守白. 新中国在血吸虫病防治研究上的成就[J]. 科学通报, 1960, 5(12): 368-371.)
[22]	Su Dl. Research progress of schistosomiasis japonicum in recent years[J]. Natl Med J China, 1950, 36(1): 35-50. (in Chinese)
	( 苏德隆. 近年日本血吸虫病研究之进展[J]. 中华医学杂志, 1950, 36(1): 35-50.)
[23]	Su DL. Observation on the distribution of oncomelania hupensis in Jiading River in summer (one of the ecological studies on Oncomelania hupensis)[J]. Chin J Prev Med, 1955(3): 179-186. (in Chinese)
	苏德隆. 嘉定河岸夏季钉螺分布的观察(钉螺生态学研究之一)[J]. 中华预防医学杂志, 1955(3): 179-186.)
[24]	Liu YF, Peng Y, Liu FX. A brief review on Oncomelania hupensis control in China[J]. Sichuan J Zool, 2005, 24(4): 651-654. (in Chinese)
	( 刘颖芳, 彭宇, 刘凤想. 中国灭螺技术的研究进展[J]. 四川动物, 2005, 24(4): 651-654.)
[25]	Mao SB, Huang MX. Study on prevention and control of schistosomiasis and its theoretical basis[J]. Chin Sci Bull, 1964, 9(11): 963-972. (in Chinese)
	( 毛守白, 黄铭新. 血吸虫病的防治及其理论基础的研究[J]. 科学通报, 1964, 9(11): 963-972.)
[26]	Chen C. Molluscicides and their application in China[J]. Chin J Schisto Control, 2003, 15(5): 321-322. (in Chinese)
	( 陈昌. 我国的杀螺剂及其应用[J]. 中国血吸虫病防治杂志, 2003, 15(5): 321-322.)
[27]	Lin DD, Wu HW, Wu GL, et al. Review and evaluation on optimal combined strategies for schistosomiasis control in China[J]. Chin J Schisto Control, 2007, 19(3): 234-237. (in Chinese)
	( 林丹丹, 吴海玮, 吴观陵, 等. 中国血吸虫病防治策略优化组合的回顾与评估[J]. 中国血吸虫病防治杂志, 2007, 19(3): 234-237.)
[28]	Wu KH, Lin XR. General situation of schistosomiasis control in Minhou County[J]. Fujian Med J, 2001, 23(5): 192. (in Chinese)
	( 吴可华, 林鲜容. 闽侯县血吸虫病的防制概况[J]. 福建医药杂志, 2001, 23(5): 192.)
[29]	Xu JS. Longitudinal observation of 12 years’ effect of sodium pentachlorophenol on snail leaching in a large area of lake beach[J]. Jiangsu Med J, 1986, 12(1): 42. (in Chinese)
	( 徐健生. 大面积湖滩矮围五氯酚钠药浸灭螺效果十二年纵向观察[J]. 江苏医药, 1986, 12(1): 42.)
[30]	Xu ZY, Su ZJ, Jiang QW, et al. Dedicated to scientific research and public service: in memory of Su The Lung, a master of preventive medicine in China[J]. Chin J Dis Control Prev, 2019, 23(10): 1301-1304. (in Chinese)
	( 徐志一, 苏竹君, 姜庆五, 等. 献身科研、服务大众: 中国预防医学界巨匠苏德隆[J]. 中华疾病控制杂志, 2019, 23(10): 1301-1304.)
[31]	Yu Q, Zhao GM, Guo JG. Evolvement of comprehensive strategy on schistosomiasis control in various control phases in China[J]. J Pathog Biol, 2006, 1(6): 470-473. (in Chinese)
	( 余晴, 赵根明, 郭家钢. 我国不同阶段实施综合治理措施控制血吸虫病策略演变[J]. 中国病原生物学杂志, 2006, 1(6): 470-473.)
[32]	Yang K, Li SZ. Appropriate techniques for schistosomiasis control and elimination[M]. Beijing: People’s Medical Publishing House, 2020: 13. (in Chinese)
	( 杨坤, 李石柱. 血吸虫病控制和消除适宜技术[M]. 北京: 人民卫生出版社, 2020: 13.)
[33]	Yuan HC. Epidemiological features and control of schistosomiasis japonica in China[J]. Memórias Do Instituto Oswaldo Cruz, 1992, 87: 241.
[34]	Liu W, Liu Y. Progress in diagnosis and research of Schistosomiasis japonicum[J]. Shanghai J Anim Husb Vet Med, 2005(4): 10-11. (in Chinese)
	( 刘伟, 刘毅. 日本血吸虫病诊断及研究进展[J]. 上海畜牧兽医通讯, 2005(4): 10-11.)
[35]	Yan ZZ, Lv ZY. Preliminary study on immunoenzyme labeling technology and its application[J]. Natl Med J China, 1978, 58(8): 470-473. (in Chinese)
	( 严自助, 吕再婴. 免疫酶标记技术及其应用的初步研究[J]. 中华医学杂志, 1978, 58(8): 470-473.)
[36]	Shi YE. Etiology and immunological diagnosis of schistosomiasis[J]. J Pract Rural Doc, 1995(1): 23-26. (in Chinese)
	( 石佑恩. 血吸虫病的病原学与免疫学诊断[J]. 实用乡村医生杂志, 1995(1): 23-26.)
[37]	Webbe G, James C. A comparison of the susceptibility to praziquantel of Schistosoma haematobium, S. japonicum, S. mansoni, S. intercalatum and S. mattheei im hamsters[J]. Zeitschrift Fur Parasitenkunde Berlin Ger, 1977, 52(2): 169-177.
[38]	Davis A, Biles JE, Ulrich AM. Initial experiences with praziquantel in the treatment of human infections due to Schistosoma haematobium[J]. Bull World Health Organ, 1979, 57(5): 773-779.
[39]	Katz N, Rocha RS, Chaves A. Preliminary trials with praziquantel in human infections due to Schistosoma mansoni[J]. Bull World Health Organ, 1979, 57(5): 781-785.
[40]	Feldmeier H, Zwingenberger K, Steiner A, et al. Praziquantel compared to niridazole in schistosomiasis intercalatum therapy[J]. Tropenmedizin Und Parasitol, 1981, 32(1): 39-42.
[41]	Nash TE, Hofstetter M, Cheever AW, et al. Treatment of Schistosoma mekongi with praziquantel: a double-blind study[J]. Am J Trop Med Hyg, 1982, 31(5): 977-982. pmid: 6751116
[42]	Huang LS. Praziquantel is a new anti-schistosomiasis drug[J]. Chin J Pharm, 1979, 10(6): 22-29. (in Chinese)
	( 黄兰孙. 抗血吸虫病新药吡喹酮[J]. 医药工业, 1979, 10(6): 22-29.)
[43]	Wang QN, Liu YH. Praziquantel, a new anti-schistosomiasis drug[J]. Sichuan Med J, 1980, 1(2): 93-94. (in Chinese)
	( 王其南, 刘约翰. 抗血吸虫病新药: 吡喹酮[J]. 四川医学, 1980, 1(2): 93-94.)
[44]	Chen MG. Use of praziquantel for clinical treatment and morbidity control of schistosomiasis japonica in China: a review of 30 years’ experience[J]. Acta Trop, 2005, 96(2): 168-176. doi: 10.1016/j.actatropica.2005.07.011
[45]	Autonomous Region Schistosomiasis Research Committee Praziquantel Cooperation Group 13 Provinces and Cities in South China. Study on praziquantel, a new anti-schistosomiasis drug[J]. Chin Med J, 1980, 60(3): 129-132. (in Chinese)
	( 自治区血吸虫病研究委员会吡喹酮协作组南方十三省市. 抗血吸虫病新药吡喹酮的研究[J]. 中华医学杂志, 1980, 60(3): 129-132.)
[46]	Chen Y, Xie MS, Wang FH, et al. Effect of chemotherapy on controlling schistosomiasis in Hunan Province[J]. Chin J Schisto Control, 1998, 10(5): 294-297. (in Chinese)
	( 陈焱, 谢木生, 王福海, 等. 湖南省化疗控制人群血吸虫病效果分析[J]. 中国血吸虫病防治杂志, 1998, 10(5): 294-297.)
[47]	Yuan HC, Yang QJ, Jiang QW, et al. Study on the factors affecting the prevalence and epidemiologieal pttern cf schistosomiasis japonica in the marshland and lake regions[J]. Chin J Schisto Control, 1990, 2(2): 14-21. (in Chinese)
	( 袁鸿昌, 杨求吉, 姜庆五, 等. 江湖洲滩地区血吸虫病流行因素和流行规律的研究[J]. 中国血吸虫病防治杂志, 1990, 2(2): 14-21.)
[48]	Zhang LJ, Shen DW. Evolution of schistosomiasis control strategies in China[J]. J Hubei Univ Sci Technol Med Sci, 2013, 27(5): 457-460. (in Chinese)
	张丽君, 沈定文. 我国血吸虫病防治策略的演变[J]. 湖北科技学院学报(医学版), 2013, 27(5): 457-460.)
[49]	Zhang KY. Evolution of schistosomiasis control strategies in China[J]. Mil Med J Southeast China, 2009, 11(4): 340-342. (in Chinese)
	( 张克宇. 我国血吸虫病防治策略的演变[J]. 东南国防医药, 2009, 11(4): 340-342.)
[50]	Zhou XN, Wang TP, Wang LY, et al. The current status of schistosomiasis epidemics in China[J]. Chin J Epidemiol, 2004, 25(7): 555-558. (in Chinese)
	( 周晓农, 汪天平, 王立英, 等. 中国血吸虫病流行现状分析[J]. 中华流行病学杂志, 2004, 25(7): 555-558.)
[51]	Utzinger J, Zhou XN, Chen MG, et al. Conquering schistosomiasis in China: the long march[J]. Acta Trop, 2005, 96(2): 69-96. doi: 10.1016/j.actatropica.2005.08.004
[52]	Engels D, Wang LY, Palmer KL. Control of schistosomiasis in China[J]. Acta Trop, 2005, 96(2/3): 67-68. doi: 10.1016/j.actatropica.2005.07.004
[53]	Yao XM, Zhao ZY, Zhou YC, et al. Three years of longitudinal observation on endemic situation of schistosomiasis in a subtype of islet with embankment in Dongting Lake regions of Hunan Province[J]. Pract Prev Med, 2005, 12(6): 1271-1273. (in Chinese)
	( 姚孝明, 赵正元, 周应彩, 等. 湖南省洞庭湖洲垸亚型血吸虫病疫情3年纵向观察[J]. 实用预防医学, 2005, 12(6): 1271-1273.)
[54]	Hu SG, Qing ST, Shi ZG, et al. Study on epidemiology and control technology of schistosomiasis in pigs in Dongting Lake area[J]. Chin J Vet Parasitol, 1997, 5(1): 37-39, 18. (in Chinese)
	( 胡述光, 卿上田, 石中谷, 等. 洞庭湖区生猪血吸虫病流行病学及防制技术研究[J]. 中国兽医寄生虫病, 1997, 5(1): 37-39, 18.)
[55]	Yang RQ, Ao H, Peng XS, et al. Effect of one-year intermittent chemotherapy on schistosomiasis in 8 villages in embankment[J]. Pract Prev Med, 1995, 2(1): 21-22. (in Chinese)
	( 杨瑞青, 敖虹, 彭喜松, 等. 洲垸型8个村化疗间歇一年对血吸虫病流行的影响[J]. 实用预防医学, 1995, 2(1): 21-22.)
[56]	Colley DG, Bustinduy AL, Secor WE, et al. Human schistosomiasis[J]. Lancet, 2014, 383(9936): 2253-2264. doi: 10.1016/S0140-6736(13)61949-2
[57]	da Paixão Siqueira L, Fontes DAF, Aguilera CSB, et al. Schistosomiasis: drugs used and treatment strategies[J]. Acta Trop, 2017, 176: 179-187. doi: S0001-706X(17)30681-2 pmid: 28803725
[58]	Shekhar KC. Schistosomiasis drug therapy and treatment considerations[J]. Drugs, 1991, 42(3): 379-405. pmid: 1720380
[59]	Zhou XN. Epidemiological characteristics and scientific research emphasis of schistosomiasis in China[J]. Chin J Endem, 2006, 25(5): 473-474. (in Chinese)
	( 周晓农. 我国血吸虫病流行特点与科学研究重点[J]. 中国地方病学杂志, 2006, 25(5): 473-474.)
[60]	Guo JG, Ning A, Hu GH, et al. The field trial on the control of schistosomiasis by treatment of buffaloes with chemotherapy in the Poyang Lake region of Jiangxi Province[J]. Chin J Zoonoses, 2005, 21(10): 860-862. (in Chinese)
	( 郭家钢, 宁安, 胡广汉, 等. 水牛化疗控制鄱阳湖地区血吸虫病传播的现场实验研究[J]. 中国人兽共患病杂志, 2005, 21(10): 860-862.)
[61]	Guo JG. Prevalence and control of schistosomiasis hillbilis in China[J]. Chin J Prev Med, 2008, 42(8): 547-548. (in Chinese)
	( 郭家钢. 我国山丘型血吸虫病的流行与防治[J]. 中华预防医学杂志, 2008, 42(8): 547-548.)
[62]	Mao SP. Epidemiology and control of schistosomiasis in the People’s Republic of China[J]. Memórias Do Instituto Oswaldo Cruz, 1987, 82(suppl 4): 77-82. doi: 10.1590/S0074-02761987000800012
[63]	Su ZW, Hu CQ, Fu Y, et al. Role of several hosts in transmission of schistosomiasis japonica in lake region[J]. Chin J Parasitol Parasit Dis, 1994, 12(1): 48-51. (in Chinese)
	( 苏卓娃, 胡采青, 傅义, 等. 不同宿主在湖区日本血吸虫病传播中的作用[J]. 中国寄生虫学与寄生虫病杂志, 1994, 12(1): 48-51.)
[64]	Gray DJ, Williams GM, Li YS, et al. Transmission dynamics of Schistosoma japonicum in the lakes and marshlands of China[J]. PLoS One, 2008, 3(12): e4058. doi: 10.1371/journal.pone.0004058
[65]	Wang LD, Chen HG, Guo JG, et al. A strategy to control transmission of Schistosoma japonicum in China[J]. N Engl J Med, 2009, 360(2): 121-128. doi: 10.1056/NEJMoa0800135
[66]	Yang K, Li HJ, Yang WC, et al. Effect of comprehensive schistosomiasis control measures with emphasis on infectious source control in dam areas of mountainous region, Yunnan Province[J]. Chin J Schisto Control, 2009, 21(4): 272-275. (in Chinese)
	( 杨坤, 李宏军, 杨文灿, 等. 云南省山丘平坝型流行区以传染源控制为主的血吸虫病综合防治措施效果评价[J]. 中国血吸虫病防治杂志, 2009, 21(4): 272-275.)
[67]	Wang TP, Cao ZG, Chen HG, et al. Changes of control strategy and improvement of schistosomiasis control in China[J]. Chin J Schisto Control, 2009, 21(4): 241-242. (in Chinese)
	( 汪天平, 操治国, 陈红根, 等. 实现防治策略转变加快血防工作进程[J]. 中国血吸虫病防治杂志, 2009, 21(4): 241-242.)
[68]	Wang LD. The key to controlling schistosomiasis epidemic in China is to manage human and livestock feces well[J]. Chin J Epidemiol, 2005, 26(12): 929-930. (in Chinese)
	( 王陇德. 中国控制血吸虫病流行的关键是管理好人畜粪便[J]. 中华流行病学杂志, 2005, 26(12): 929-930.)
[69]	Zhang LJ, Xu ZM, Qian YJ, et al. Endemic status of schistosomiasis in People’s Republic of China in 2015[J]. Chin J Schisto Control, 2016, 28(6): 611-617. (in Chinese)
	( 张利娟, 徐志敏, 钱颖骏, 等. 2015年全国血吸虫病疫情通报[J]. 中国血吸虫病防治杂志, 2016, 28(6): 611-617.)
[70]	Zhang LJ, Xu ZM, Dai SM, et al. Endemic status of schistosomiasis in People’s Republic of China in 2017[J]. Chin J Schisto Control, 2018, 30(5): 481-488. (in Chinese)
	( 张利娟, 徐志敏, 戴思敏, 等. 2017年全国血吸虫病疫情通报[J]. 中国血吸虫病防治杂志, 2018, 30(5): 481-488.)
[71]	Zhang LJ, Xu ZM, Dang H, et al. Endemic status of schistosomiasis in People’s Republic of China in 2019[J]. Chin J Schisto Control, 2020, 32(6): 551-558. (in Chinese)
	( 张利娟, 徐志敏, 党辉, 等. 2019年全国血吸虫病疫情通报[J]. 中国血吸虫病防治杂志, 2020, 32(6): 551-558.)
[72]	Liu XP, Cao ZG, Wang TP. Role of different final hosts in schistosomiasis transmission[J]. J Trop Dis Parasitol, 2013, 11(1): 54-58. (in Chinese)
	( 刘效萍, 操治国, 汪天平. 不同终宿主在血吸虫病传播中的作用[J]. 热带病与寄生虫学, 2013, 11(1): 54-58.)
[73]	WHO. WHO guideline on control and elimination of human schistosomiasis[R]. Geneva: WHO, 2022.